2022
DOI: 10.1016/j.ejpsy.2021.12.001
|View full text |Cite
|
Sign up to set email alerts
|

Acceptance of the disease and quality of life in patients with type 1 and type 2 diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…The subjective assessement of the patients' quality of life is affected by clinical, as well as social and demographic factors [22], which is also indicated by other researchers from Central Europe [23].…”
Section: Discussionmentioning
confidence: 80%
See 1 more Smart Citation
“…The subjective assessement of the patients' quality of life is affected by clinical, as well as social and demographic factors [22], which is also indicated by other researchers from Central Europe [23].…”
Section: Discussionmentioning
confidence: 80%
“…The issue of the QoL is also addressed by the International Diabetes Federation which considers the quality of life as one of the fundamental goals of diabetes care, along with metabolic control and prevention. This is because it has been proven that laboratory results which are so important for physicians, are important for patients with DM only to the extent that they affect their physical, emotional and social well-being, namely the quality of life [22].…”
Section: Discussionmentioning
confidence: 99%
“…The results are consistent with those of other authors. In a study by Badura-Brzoza et al (2022), the level of disease acceptance was 29.7 points in patients with type 1 diabetes and 31.6 points in those with type 2 diabetes [31]. Bonikowska et al (2021) demonstrated that the level of AIS was 28.5 points in elderly patients with type 2 diabetes [32].…”
Section: Discussionmentioning
confidence: 96%
“…Two previous studies demonstrated higher SWLS-scores in the general population (mean 25.6 ± 5.3 in men, 25.7 ± 5.8 in women) ( 19 ) and in healthy young adults (26.18 ± 5.72) ( 20 ). Lower SWLS-scores were demonstrated in patients with active Crohn's disease (mean 20.8 ± 8.6 in men, 20.9 ± 7.8 in women) ( 11 ), patients with psychiatric disorders (mean 20.1 ± 7.8) ( 21 ), type 2 diabetes mellitus (mean 20.0 ± 5.0) ( 22 ), and in Parkinson disease (mean 21.6 ± 7.0 in men, 20.4 ± 6.2 in women) ( 23 ). Our results are comparable with a study by Sarid et al with similar SWLS-scores in patients with Crohn's disease in remission (23.8 ± 6.4 in men, 23.8 ± 6.7 in women) ( 11 ).…”
Section: Discussionmentioning
confidence: 99%